Chi-Iou Lin

Center for Vascular Biology Research, Harvard Medical School

Affiliated withHarvard Medical School

Research Area

Biography

Chi-Iou Lin has not added Biography.
If you are Chi-Iou Lin and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 15	2014

Other Publications

Article	Year
Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism. American journal of physiology. Cell physiology\| PubMed ID: 15294853	2004
Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. Endocrinology\| PubMed ID: 15878967	2005
Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism. Journal of cellular biochemistry\| PubMed ID: 16795034	2006
Sphingosine 1-phosphate regulates inflammation-related genes in human endothelial cells through S1P1 and S1P3. Biochemical and biophysical research communications\| PubMed ID: 17331465	2007
Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3. Biochemical and biophysical research communications\| PubMed ID: 17923111	2007
Lysophosphatidic acid stimulates thrombomodulin lectin-like domain shedding in human endothelial cells. Biochemical and biophysical research communications\| PubMed ID: 18167312	2008
Establishment of a fluorescence resonance energy transfer-based bioassay for detecting dioxin-like compounds. Journal of biomedical science\| PubMed ID: 18604597	2008
Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivati... Cellular signalling\| PubMed ID: 18627789	2008
Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells. Biochemical and biophysical research communications\| PubMed ID: 19124005	2009
Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer. Molecular cancer research : MCR\| PubMed ID: 19825987	2009
Autophagy: a new target for advanced papillary thyroid cancer therapy. Surgery\| PubMed ID: 19958950	2009
Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation. Thyroid : official journal of the American Thyroid Association\| PubMed ID: 20470206	2010
Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer. Molecular cancer research : MCR\| PubMed ID: 20736296	2010
Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer. The Journal of clinical endocrinology and metabolism\| PubMed ID: 21190978	2011
Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers. Surgery\| PubMed ID: 22136818	2011
Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity. Surgery\| PubMed ID: 22136853	2011
Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers. Biochemical and biophysical research communications\| PubMed ID: 22521882	2012
Strategic combination therapy overcomes tyrosine kinase coactivation in adrenocortical carcinoma. Surgery\| PubMed ID: 23102636	2012
Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer. Surgery\| PubMed ID: 23158184	2012